Lakewood Capital Opens Shorts In Seagate, Diplomat Pharmacy, Ziopharm OncologyRupert Hargreaves
Lakewood Capital Management, the hedge fund managed by Anthony T. Bozza, recorded a net loss of 2.4% for the third quarter, according to the fund’s third quarter letter to partners reviewed by ValueWalk.
In Lakewood’s words the performance, “underscored the fund’s conservative orientation and careful approach to risk management”. Long equity positions generated a -9% return on capital, hedged long equity positions generated a -4% return on . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible